XML 18 R7.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash Flows From Operating Activities    
Net income $ 15,778 $ 10,215
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 48,779 46,081
Gain on disposition of property (13,170) 0
Amortization of non-cash items within interest expense 2,175 2,076
Amortization of acquired above- and below-market leases, net (798) (514)
Amortization of acquired below-market ground leases 1,958 1,958
Straight-lining of rental revenue (5,283) (3,061)
Equity based compensation 4,980 3,449
Loss on early extinguishment of debt 0 553
Increase (decrease) in cash flows due to changes in operating assets and liabilities:    
Security deposits 2,136 (10,042)
Tenant and other receivables 2,356 (1,371)
Deferred costs (7,812) (8,105)
Prepaid expenses and other assets 31,809 29,132
Accounts payable and accrued expenses 250 141
Deferred revenue and other liabilities (12) 414
Net cash provided by operating activities 83,146 70,926
Cash Flows From Investing Activities    
Additions to building and improvements (42,063) (53,000)
Acquisition of non-controlling interests in other partnerships 0 (14,226)
Post-closing costs from a prior period sale of property 0 (4,034)
Development costs 0 (9)
Net cash used in investing activities (42,063) (71,269)
Cash Flows From Financing Activities    
Repayment of unsecured term loan (100,000) 0
Proceeds from unsecured revolving credit facility 0 120,000
Repayment of unsecured revolving credit facility (120,000) 0
Proceeds from unsecured term loan 0 95,000
Repayment of unsecured term loan 0 (215,000)
Repayment of mortgage notes payable (889) (1,470)
Deferred financing costs (404) (9,280)
Taxes paid on withholding shares (897) 0
Private perpetual preferred unit distributions (1,050) (1,050)
Distributions (9,733) (9,502)
Net cash used in financing activities (232,973) (21,302)
Net decrease in cash and cash equivalents and restricted cash (191,890) (21,645)
Cash and cash equivalents and restricted cash—beginning of period 429,302 406,956
Cash and cash equivalents and restricted cash—end of period 237,412 385,311
Reconciliation of Cash and Cash Equivalents and Restricted Cash:    
Cash and cash equivalents at beginning of period 385,465 346,620
Restricted cash at beginning of period 43,837 60,336
Cash and cash equivalents at end of period 187,823 333,573
Restricted cash at end of period 49,589 51,738
Cash and cash equivalents and restricted cash 237,412 385,311
Supplemental disclosures of cash flow information:    
Cash paid for interest 20,357 21,984
Cash paid for income taxes 1,220 480
Non-cash investing and financing activities:    
Building and improvements included in accounts payable and accrued expenses 79,042 48,771
Write-off of fully depreciated assets 9,270 551
Derivative instruments at fair values included in prepaid expenses and other assets 7,035 16,726
Contract asset (171,003) 0
Debt associated with property in receivership 177,667 0
Accrued interest associated with property in receivership 6,080 0
Conversion of operating partnership units to ESRT partner's capital $ 1,585 $ 7,132